27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell to a new 52-week low of $10.50 after Bill Ackman sold his stake.
Pershing Square, the activist investor's firm, exited its 27.2 million share position at $11. Ackman will also step off the company's board.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
David Maris of Wells Fargo reiterated his Underperform rating on the stock and the $11 sale price comes within his valuation range of $10-$13. Investors might consider Ackman’s exit as a sign Valeant may not see a major turnaround in the next several years.
“[W]e see this as a vote of no confidence for the stock and that things are continuing to go from bad to worse for Valeant,” Maris wrote in a note.
Maris said investors will take Pershing Square’s exit as a reflection that:
- “The outlook is negative”
- “The potential for meaningful near-term asset sales is unlikely”
- “The legal proceedings/investigations may have greater risk than the Street is appreciating”
- “A turnaround will take longer than expected or is not possible”
- “The debt holders have an advantaged position in the capital structure, and as such the equity holders are at their mercy, especially in a bankruptcy situation.”
The analyst pointed out Valeant is in a challenging situation as it's set to launch an expensive-to-market drug into a crowded market with a worse-than-peers safety profile and weak core product trends.
The company is also burdened with several investigations and lawsuits and more than $29 billion of debt and obligations.
“We believe Valeant shares currently carry too much risk for us to be comfortable recommending them as an investment,” Maris added.
Related:
How Much Money Did Bill Ackman Lose In Valeant?
Pershing Square's Valeant Sale Sends 'Untimely Poor Signal'
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.